11:49 AM EST - Valeant Pharmaceuticals International, Inc. : announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the previously announced tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. for all of the outstanding shares of common stock of Solta Medical, Inc. at a price of $2.92 per share, net to the seller in cash, without interest (less any required withholding taxes) and subsequent merger of Purchaser with Solta expired at 11:59 p.m., New York City time on January 14. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $1.81 at $145.70.
